BioCision to offer sneak preview of CoolBox technology at ASM annual meeting

NewsGuard 100/100 Score

BioCision LLC, a leader in advanced temperature management of biomedical samples, will be offering a sneak preview of their latest product, the CoolBox XT, at the American Society for Microbiology Annual Meeting, being held in San Francisco June 17-22.    

Expanding on innovative benchtop CoolBox technology, the CoolBox XT workstations are designed for extended ice-free cooling (up to 18 hours) and include CoolRack modules that are compatible with automation platforms. This patent-pending technology does not require power, allowing it to be used in the laboratory as an alternative to the ice bucket, eliminating ice-related issues such as sample degradation due to contamination. It can also serve as a portable sample transport device.

"Our new CoolBox XT technology addresses laboratory demands for extended cooling technology that provides the temperature of ice, without the intrinsic problems that come with its use," said Rolf Ehrhardt, CEO, BioCision. "The CoolBox XT workstation outperforms currently available systems based on its extended cooling and freezing times, independence from power, and unique size options."

The CoolBox XT will be displayed at BioCision booth #1240 and will be available for purchase in July.   

Source: BioCision

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech